Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Return on Assets (2016 - 2025)

Seres Therapeutics' Return on Assets history spans 11 years, with the latest figure at 0.91% for Q2 2025.

  • For Q2 2025, Return on Assets rose 135.0% year-over-year to 0.91%; the TTM value through Jun 2025 reached 0.91%, up 135.0%, while the annual FY2024 figure was 0.51%, 29.0% up from the prior year.
  • Return on Assets for Q2 2025 was 0.91% at Seres Therapeutics, up from 0.88% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.91% in Q2 2025 and bottomed at 0.79% in Q3 2022.
  • The 5-year median for Return on Assets is 0.26% (2022), against an average of 0.14%.
  • The largest annual shift saw Return on Assets crashed -69bps in 2022 before it skyrocketed 135bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.17% in 2021, then tumbled by -222bps to 0.55% in 2022, then grew by 23bps to 0.43% in 2023, then skyrocketed by 285bps to 0.79% in 2024, then increased by 15bps to 0.91% in 2025.
  • Per Business Quant, the three most recent readings for MCRB's Return on Assets are 0.91% (Q2 2025), 0.88% (Q1 2025), and 0.79% (Q4 2024).